Aerin to Invest in  Studies and New Products with $48M New Equity

Aerin to Invest in Studies and New Products with $48M New Equity

Aerin Medical, a privately held medical device company focused on non-invasive procedures for treating nasal airway conditions, has closed a $48 million equity financing. Nasal airway obstruction conditions affect tens of millions of people in the U.S. annually.Aerin Medical provides...

Latest News

Cardiology

Approvals / Clearance

Clinical Studies / Trials

Rezūm™ Water Vapor BPH Therapy Effective After Five Years

New clinical study results say the Rezūm System provided significant, sustained improvement of...

read the full article >

First Patient in SELUTION SLR™ Study for AV Fistula

MedAlliance has announced enrollment of the first patient in the SAVE* study utilizing their novel...

read the full article >